⌘K

Login Start Free

Home/Filings/4/0001062993-21-012061

4//SEC Filing

VANLENT ANNE 4

Accession 0001062993-21-012061

CIK 0001273636other

View on SEC.gov Company Profile

Filed

Dec 1, 7:00 PM ET

Accepted

Dec 2, 7:00 PM ET

Size

5.1 KB

Accession

0001062993-21-012061

Insider Transaction Report

Form 4

Period: 2021-11-30

APPLIED GENETIC TECHNOLOGIES CORPAGTC

Director

Transactions

Award
Stock Option (right to buy)
2021-11-30+14,000→ 14,000 total
Exercise: $2.17Exp: 2031-11-30→ Common Stock (14,000 underlying)

Footnotes (1)

[F1]The option becomes exercisable in equal monthly installments over one year from the date of grant.

Documents

1 file

4
form4.xmlPrimary
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES

Issuer

APPLIED GENETIC TECHNOLOGIES CORP

CIK 0001273636

Entity typeother

Related Parties

1

filerCIK 0001229243

Filing Metadata

Form type: 4
Filed: Dec 1, 7:00 PM ET
Accepted: Dec 2, 7:00 PM ET
Size: 5.1 KB

View on SEC.gov